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Rabies was first detected in the Sultanate of Oman in 
1990, when a child from Buraimi, northern Oman, on the 
border with the United Arab Emirates (U.A.E), died after 
being bitten by a fox.’ Subsequently, animal-bite surveil- 
lance revealed evidence of a country-wide epizootic of 
rabies in the common fox (Vulpes vulpes), which spread 
from the border of the U.A.E. to involve the whole of 
Oman, excepting Musandem Province in the northeast2s3 
Shortly after the first case, postexposure prophylactic 
immunization for rabies (passive immunization with 
human rabies immune globulin [HRIG] and active immu- 
nization with human diploid cell vaccine [HDCV]), was 
made available in all Omani hospitals. Nevertheless, 
despite adequate postexposure prophylaxis, two more 
cases of rabies occurred in 1991 and 1992, following bites 
by a wolf and a fox, respectively.* This report presents 
another case of rabies that developed despite postexpo- 
sure immunization in a lactating woman who was bitten 
by a fox. 
On April 20,1997, while sleeping in the desert, a 17- 
year-old Bedouin woman was bitten on the upper lip by 
a fox. Her husband immediately drove her to the district 
hospital, where two deep lacerations on her upper lip 
were cleaned and dressed, but not stitched. Two 1-mL 
doses of inactivated Merieux rabies HDCV were admin- 
istered by intramuscular injection into each deltoid, 
according to the Ministry of Health protocol. Antitetanus 
toxoid was given. At the time, HRIG was unavailable in 
the hospital, but the woman was ordered to go immedi- 
ately to the regional hospital, a distance of several hours’ 
drive on a surfaced road, where HRIG was available. 
Unfortunately, she delayed attending the regional hospi- 
tal until April 22, when, according to official guidelines 
for patients presenting more than 48 hours after injury, 
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she was given 800 international units (20 IU/kg body 
weight) of Merieux HRIG intramuscularly into the 
gluteal region only (with no infiltration of the wound). 
Since Oman followed the 2-l-l regimen (two l.O-mL 
doses of HDCV on day 0, and one dose on days 7 and 
2 1, respectively) for vaccine administration5 on April 
26, she was given the third I-mL dose of HDCV into the 
deltoid muscle. 
On May 3, the patient developed fever, headache, and 
vomiting, and on May 7, presented to the district hospi- 
tal with fever, delirium, hyperesthesia, and aerophobia. 
She was referred at once to the Sultan Qaboos University 
Hospital as a case of suspected rabies. She brought her 
7-month-old infant boy with her; she had continued to 
breastfeed the child despite being bitten by the fox. On 
admission, the patient was febrile, agitated, confused, and 
had hydrophobia. There were two healed lacerations on 
her upper lip (Figure 1). She had signs of brain stem dys- 
function, including a right sixth cranial nerve palsy, but no 
signs of meningitis. The clinical diagnosis of rabies was 
confirmed, and she was transferred to the Intensive Care 
Unit, where she was sedated, paralyzed, and given assisted 
ventilation. The patient died May 9,1997. Prior to decease, 
a skin biopsy was taken from the back of the neck, and 
corneal impressions and washings were obtained. A pos- 
itive fluorescent antibody test for rabies virus was obtained 
only from the cornea1 washings. Serum was obtained for 
rabies antibody measurement, but unfortunately, the spec- 
imen was not processed and was discarded. The infant 
received HRIG on admission, and a full course of HDCV 
was administered. He remained well. 
DISCUSSION 
Although the patient received immunization with HDCV 
within a few hours of being bitten, the delay of over 48 
hours before she received HRIG may have contributed to 
the development of rabies. In addition, the two lacera- 
tions on her upper lip were very deep, and presumably 
virus was injected close to, or directly into facial nerve 
tissue. 
In two previous cases of failed postexposure immu- 
nization in Oman, which occurred in 1991 and 1992,* 
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Figure 1. Patient with rabies. Arrows indicate site of bite. 
multiple, deep penetrating injuries of the face and scalp 
were sustained. The first patient, a 45-year-old woman, 
was severely bitten on the face (with severance of the left 
facial nerve), scalp, neck, and arm, by a wolf (Can& lupus 
arabs). Within 5 hours, she received two I-mL doses of 
inactivated Merieux rabies HDCV intramuscularly into 
each deltoid, 600 IU (20 IU/kg) of Merieux HRIG into 
the wounds, and 600 IU into the gluteal muscles. On day 
7, she received 1 mL HDCV by intramuscular injection 
into the deltoid. Rabies developed on day 13, and she 
died in a coma on day 18. Rabies virus was detected in 
cornea1 impressions, using the fluorescent antibody test. 
Serum obtained 2 days before decease, revealed rabies 
antibodies at a titer of 1:810 in the neutralizing cell-cul- 
ture test. Three other patients bitten on the same day by 
the same wolf, including two who had multiple, severe 
bites on the face and head, were similarly immunized and 
remained well. 
The second patient, a j-month-old female child, was 
severely bitten by a fox on the face and scalp, exposing 
the pericranium. No suturing was performed. She 
received two 1-mL doses of inactivated Merieux rabies 
HDCV injected into the deltoids, 60 IU of Merieux HRIG 
infiltrated into the wounds, and 60 IU injected into the 
gluteal region. She received the second I-mL dose of 
HDCV on day 7, but developed rabies on day 14, and she 
died 2 days later. Rabies virus was identified in cornea1 
impressions by a positive fluorescent antibody test. 
Failure of prophylaxis in these two cases was attrib- 
uted to the presumed injection of a large inoculum of 
virus into nervous tissue in the face and scalp, and the 
impossibility of infiltrating the extensive, deep lacerations 
adequately. 
In Oman, the 2-l-l regimen, which is recommended 
by the World Health Organization (WHO) for develop- 
ing countries, has until now proved to be dependable. 
Many hundreds of patients have received postexposure 
prophylaxis over the past decade, and the only failures 
have been those described here. Failures have been 
reported from several countries using the 2-l-l proce- 
dure, including Thailand,6 Burkino Faso,’ and India,8 and 
in all of these, the recommended guidelines were not fol- 
lowed exactly. Failed postexposure immunization has also 
been reported recently from Fmnce.9 In the United States, 
as well as initial HRIG and HDCV, four further doses of 
HDCV are given. Failed postexposure prophylaxis has not 
been reported in humans, but it has in animals (in which 
only three doses of vaccine are given).‘O It is clear that 
whichever protocol is used for postexposure immuniza- 
tion, meticulous adherence to the recommended guide- 
lines is imperative, including appropriate dosage and 
timely administration of HDCV and HRIG. 
Continuation of lactation in the patient reported 
here may have exposed the child to the risk of rabies. 
Transient viremia occurs in rabies, and if there were 
micro-abrasions around the nipple, exposure to infec- 
tion might occur. Rabies has been transmitted by breast 
milk in animals, but confirmed cases have not been 
reported in humans. *l Virus is also present in mucous 
membranes and cornea, and could be transferred if the 
mother touched her child’s eyes after rubbing her own; 
however, person-to-person transmission of rabies has 
never been reported. Early immunization of the infant 
with HRIG and HDCV in this case, may have played a 
part in preventing infection. 
There has been one further case of rabies in Oman 
since this case. In 1999, a 13-year-old girl, was scratched 
below the right lower eyelid at night while sleeping in 
her house, by an unidentified animal, suspected to be a 
feral cat. No medical attention was sought, and 1 week 
later she developed rabies, confirmed by immunofluo- 
rescence of cornea1 impressions and washings.‘* Cats 
have rarely been identified as being rabid during the past 
10 years of animal-bite surveillance in Oman; foxes and 
dogs have usually been affected. Although a rat or a 
mouse was suspected to be the source of rabies (Lassa 
virus gentoype I> in a soldier in Israel,13 rodents are not 
regarded as a risk in Oman, and prophylactic immuniza- 
tion is not recommended. 
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